Mehra Raj, Barile Daniela, Marotta Mariarosaria, Lebrilla Carlito B, Chu Caroline, German J Bruce
Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.
Department of Food Science and Technology, University of California, Davis, Davis, California, United States of America.
PLoS One. 2014 May 8;9(5):e96040. doi: 10.1371/journal.pone.0096040. eCollection 2014.
Oligosaccharides are the third largest component in human milk. This abundance is remarkable because oligosaccharides are not digestible by the newborn, and yet they have been conserved and amplified during evolution. In addition to encouraging the growth of a protective microbiota dominated by bifidobacteria, oligosaccharides have anti-infective activity, preventing pathogens from binding to intestinal cells. Although it would be advantageous adding these valuable molecules to infant milk formula, the technologies to reproduce the variety and complexity of human milk oligosaccharides by enzymatic/organic synthesis are not yet mature. Consequently, there is an enormous interest in alternative sources of these valuable oligosaccharides. Recent research has demonstrated that bovine milk and whey permeate also contain oligosaccharides. Thus, a thorough characterization of oligosaccharides in bovine dairy streams is an important step towards fully assessing their specific functionalities. In this study, bovine milk oligosaccharides (BMOs) were concentrated by membrane filtration from a readily available dairy stream called "mother liquor", and analyzed by high accuracy MALDI FT-ICR mass spectrometry. The combination of HPLC and accurate mass spectrometry allowed the identification of ideal processing conditions leading to the production of Kg amount of BMO enriched powders. Among the BMOs identified, 18 have high-molecular weight and corresponded in size to the most abundant oligosaccharides present in human milk. Notably 6 oligosaccharides contained fucose, a sugar monomer that is highly abundant in human milk, but is rarely observed in bovine milk. This work shows that dairy streams represent a potential source of complex milk oligosaccharides for commercial development of unique dairy ingredients in functional foods that reproduce the benefits of human milk.
低聚糖是母乳中的第三大成分。这种丰富程度很显著,因为低聚糖无法被新生儿消化,但在进化过程中却得以保留并大量增加。除了促进以双歧杆菌为主的保护性微生物群的生长外,低聚糖还具有抗感染活性,可防止病原体与肠道细胞结合。尽管将这些有价值的分子添加到婴儿配方奶粉中会有诸多益处,但通过酶促/有机合成来重现母乳低聚糖的种类和复杂性的技术尚未成熟。因此,人们对这些有价值的低聚糖的替代来源有着极大的兴趣。最近的研究表明,牛乳和乳清渗透液中也含有低聚糖。因此,全面表征牛乳流中的低聚糖是充分评估其特定功能的重要一步。在本研究中,通过膜过滤从一种名为“母液”的现成乳源流中浓缩牛乳低聚糖(BMOs),并采用高精度基质辅助激光解吸电离傅里叶变换离子回旋共振质谱进行分析。高效液相色谱(HPLC)和精确质谱的结合使得能够确定理想的加工条件,从而生产出公斤级的富含BMOs的粉末。在所鉴定的BMOs中,有18种具有高分子量,其大小与母乳中最丰富的低聚糖相对应。值得注意的是,有6种低聚糖含有岩藻糖,岩藻糖是一种在母乳中含量很高但在牛乳中很少见的糖单体。这项工作表明,乳源流是功能性食品中独特乳制品成分商业开发的复杂乳低聚糖的潜在来源,这些功能性食品可重现母乳的益处。